Tower Research Capital (TRC)’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,846
| Closed | -$9K | – | 6988 |
|
|
2022
Q2 | $9K | Buy |
7,846
+5,012
| +177% | +$5.75K | ﹤0.01% | 4637 |
|
|
2022
Q1 | $14K | Buy |
2,834
+394
| +16% | +$1.95K | ﹤0.01% | 3950 |
|
|
2021
Q4 | $14K | Buy |
+2,440
| New | +$14K | ﹤0.01% | 4140 |
|
|
2021
Q3 | – | Sell |
-4,211
| Closed | -$71K | – | 6498 |
|
|
2021
Q2 | $71K | Buy |
4,211
+3,798
| +920% | +$64K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $11K | Buy |
413
+70
| +20% | +$1.86K | ﹤0.01% | 4349 |
|
|
2020
Q4 | $12K | Sell |
343
-3,885
| -92% | -$136K | ﹤0.01% | 4235 |
|
|
2020
Q3 | $150K | Buy |
4,228
+3,247
| +331% | +$115K | ﹤0.01% | 2820 |
|
|
2020
Q2 | $42K | Buy |
981
+858
| +698% | +$36.7K | ﹤0.01% | 3194 |
|
|
2020
Q1 | $10K | Sell |
123
-13
| -10% | -$1.06K | ﹤0.01% | 2052 |
|
|
2019
Q4 | $13K | Buy |
+136
| New | +$13K | ﹤0.01% | 2221 |
|
|
2016
Q1 | – | Sell |
-4
| Closed | -$1K | – | 5218 |
|
|
2015
Q4 | $1K | Sell |
4
-25
| -86% | -$6.25K | ﹤0.01% | 4228 |
|
|
2015
Q3 | $21K | Buy |
+29
| New | +$21K | ﹤0.01% | 1699 |
|